|
CMC BIOLOGICS COMPLETES
A FINANCING ROUND WITH MONITOR
CLIPPER
COPENHAGEN, DENMARK,
28th
February 2008
CMC Biologics A/S (CMC,
formerly CMC Biopharmaceuticals
A/S) announced
today that it has closed
a share capital offering which
was arranged as part of the
Company’s financial strategy in
connection with its
recent acquisition of
ICOS
Biologics Manufacturing. Funds
managed by Monitor Clipper
Partners, LLC (MCP or
Monitor Clipper) led the
transaction, which also included
follow-on investments from
EEP
and other existing
investors. The financing round
also provided liquidity for
certain original shareholders of
CMC.
The financing will be employed
for the development and
build-out of ICOS Biologics
Manufacturing facilities as
well as for operational
and working capital purposes
Read the
whole press release here:
PDF
email:
info@cmcbio.com
web:
www.cmcbio.com
|
